ResMed Inc (RMD)
218.57
-1.40
(-0.64%)
USD |
NYSE |
May 17, 16:00
218.62
+0.05
(+0.02%)
After-Hours: 20:00
ResMed Cash from Operations (Annual): 693.30M for June 30, 2023
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| June 30, 2023 | 693.30M |
| June 30, 2022 | 351.15M |
| June 30, 2021 | 736.72M |
| June 30, 2020 | 802.26M |
| June 30, 2019 | 459.05M |
| June 30, 2018 | 505.03M |
| June 30, 2017 | 414.05M |
| June 30, 2016 | 547.93M |
| June 30, 2015 | 383.18M |
| June 30, 2014 | 391.27M |
| June 30, 2013 | 402.82M |
| June 30, 2012 | 383.16M |
| June 30, 2011 | 283.19M |
| June 30, 2010 | 188.21M |
| June 30, 2009 | 238.88M |
| June 30, 2008 | 137.84M |
| Date | Value |
|---|---|
| June 30, 2007 | 91.11M |
| June 30, 2006 | 99.03M |
| June 30, 2005 | 71.08M |
| June 30, 2004 | 76.54M |
| June 30, 2003 | 59.28M |
| June 30, 2002 | 35.64M |
| June 30, 2001 | 29.52M |
| June 30, 2000 | 20.28M |
| June 30, 1999 | 18.20M |
| June 30, 1998 | 6.80M |
| June 30, 1997 | 9.50M |
| June 30, 1996 | 3.50M |
| June 30, 1995 | 0.70M |
| June 30, 1994 | 1.60M |
| June 30, 1993 | 1.00M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Annual) Range, Past 5 Years
351.15M
Minimum
2022
802.26M
Maximum
2020
608.49M
Average
693.30M
Median
2023
Cash from Operations (Annual) Benchmarks
| Boston Scientific Corp | 2.503B |
| Align Technology Inc | 785.78M |
| Stryker Corp | 3.711B |
| Haemonetics Corp | 181.75M |
| Teleflex Inc | 510.64M |